Stock Taper
RGC
REGENCELL BIOSCIENCE HOLDINGS LIMITED
NASDAQ
$5.30
▼ DOWN 2.57% (-0.14)

KEY STATISTICS

Market Cap$2.63 B
52w High$69.00
52w Low$4.51
Dividend Yield318.47%
FrequencyQuarterly
P/E-373.24
Volume153.53K
Shares Out.495.47M

COMPANY

LEADERSHIP

Yat-Gai Au
CHIEF EXECUTIVE
Yat-Gai Au

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 16, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
10

UPCOMING EARNINGS

DateOct 28, 2026
DayWednesday
Rev. Est.
OCT
28
WED

SPLIT RECORD

DATETYPERATIO
2025-06-16Forward38:1

PRICE

$5.30 ▼ DOWN 2.57% (−$0.14)
OVERLAYS
$5.20$5.30$5.40$5.509:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM5.30

About Regencell Bioscience Holdings Limited

https://www.regencellbioscience.com ↗

Regencell Bioscience, founded in 2014 and based in Hong Kong, develops and commercializes Traditional Chinese Medicine for neurocognitive disorders like ADHD and autism spectrum disorder.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT REGENCELL BIOSCIENCE HOLDINGS LIMITED IS KNOWN FOR

Three standardized TCM formulae candidates for ADHD and ASD
Three standardized TCM formulae candidates for ADHD and ASD

The company develops three liquid TCM formulations targeting mild to severe ADHD and ASD, focusing on neurocognitive disorders based on their proprietary 'Sik-Kee Au TCM Brain Theory™'.

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

SENATE TRADES
Michael Bennet
Michael Bennet
Sale (Full)
2017-12-08

INSIDER TRADES

DIRECTOR
LO WILLIAM WING YAN DR
Sale · 70.6K shares
2026-05-27
DIRECTOR
HUI EVANA YEE WAH
Sale · 19.0K shares
2026-05-27
DIRECTOR
LO WILLIAM WING YAN DR
· 592.2K shares
2026-03-18
DIRECTOR
LO MARGARET HOOR HAN
· —
2026-03-18

SECTORS PEERS

PEERPRICE
AXSM$207.77COMPARE
CYTK$76.84COMPARE
ATR$134.80COMPARE
ABVX$114.95COMPARE
RYTM$110.00COMPARE
GRFS$8.00COMPARE
STVN$22.60COMPARE